VICO — Vicore Pharma Holding AB Balance Sheet
0.000.00%
- SEK2.41bn
- SEK1.58bn
- SEK109.35m
Annual balance sheet for Vicore Pharma Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 319 | 371 | 262 | 483 | 1,156 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.35 | 1.42 | 2.18 | 3.24 | 19.8 |
| Prepaid Expenses | |||||
| Total Current Assets | 328 | 378 | 270 | 496 | 1,203 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.252 | 0.401 | 0.117 | 0.025 | 0 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 407 | 451 | 338 | 498 | 1,203 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 48.1 | 65.7 | 46.4 | 41 | 72.9 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 52 | 67.9 | 48.9 | 42.4 | 73.8 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 355 | 383 | 289 | 455 | 1,129 |
| Total Liabilities & Shareholders' Equity | 407 | 451 | 338 | 498 | 1,203 |
| Total Common Shares Outstanding |